{"database": "lobbying", "table": "lobbying_activities", "rows": [[1444657, "9711f0b4-9591-4200-996a-8b57c2afd968", "3A", "BROWN RUDNICK LLP", 287895, "HOSPIRA, INC.", 2013, "third_quarter", "PHA", "-- Issues relating to generic drug labeling\n-- S. 959:  The Pharmaceutical Quality, Security and Accountability Act\n-- H.R. 3204: The Compounding Clarity Act", "HOUSE OF REPRESENTATIVES,SENATE,White House Office", 50000, null, 0, 0, "2013-10-16T15:50:59.130000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1444657"], "units": {}, "query_ms": 9.902265039272606, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}